# US 2026/0083714 A1 · Dosing regimen for treating pku with a piperidine inhibitor of slc6a19 function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083714 A1
- Document ID: US20260083714A1
- Status: Published application
- Kind: A1
- Application number: 19/111,597
- Filed: 2023-08-25
- Published: 2026-03-26
- Earliest claimed: 2022-09-14
- Assignees: Jnana Therapeutics Inc.
- Applicants: Jnana Therapeutics Inc.
- Inventors: John Peter Throup; Heather Smith Blanchette
- Web page: https://patentgrep.com/patent/US20260083714A1

## CPC

- A61K 31/445: Non condensed piperidines, e.g. piperocaine
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed are methods of treating phenylketonuria, comprising administering to a patient in need thereof an effective amount of the following compound: or a pharmaceutically acceptable salt thereof

## Claims

### Claim 1

A method of treating or preventing a disease or disorder associated with a genetic defect in phenylalanine hydroxylase, comprising orally administering to a patient in need thereof an effective amount of the following compound, or a pharmaceutically acceptable salt thereof:
wherein the compound is formulated as a tablet.

### Claim 2 (depends on 1)

The method of claim 1, wherein the amount of compound is about 5 mg/day to about 1025 mg/day.

### Claim 3 (depends on 1)

The method of claim 1, wherein the amount of compound is about 75 mg/day to about 1025 mg/day.

### Claim 4 (depends on 2)

The method of claim 2, wherein the amount of the compound is about 100 mg/day to about 500 mg/day.

### Claim 5 (depends on 2)

The method of claim 2, wherein the amount of the compound is about 500 mg/day to about 1000 mg/day.

### Claim 6 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the amount of the compound is about 100 mg/day to about 200 mg/day.

### Claim 7 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the amount of the compound is about 200 mg/day to about 300 mg/day.

### Claim 8 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the amount of the compound is about 300 mg/day to about 400 mg/day.

### Claim 9 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the amount of the compound is about 400 mg/day to about 500 mg/day.

### Claim 10 (depends on 1, 2, 3, 5)

The method of any one of claims 1-3 and 5, wherein the amount of the compound is about 500 mg/day to about 600 mg/day.

### Claim 11 (depends on 1, 2, 3, 5)

The method of any one of claims 1-3 and 5, wherein the amount of the compound is about 600 mg/day to about 700 mg/day.

### Claim 12 (depends on 1, 2, 3, 5)

The method of any one of claims 1-3 and 5, wherein the amount of the compound is about 700 mg/day to about 800 mg/day.

### Claim 13 (depends on 1, 2, 3, 5)

The method of any one of claims 1-3 and 5, wherein the amount of the compound is about 800 mg/day to about 900 mg/day.

### Claim 14 (depends on 1, 2, 3, 5)

The method of any one of claims 1-3 and 5, wherein the amount of the compound is about 900 mg/day to about 1000 mg/day.

### Claim 15 (depends on 4)

The method of claim 4, wherein the amount of the compound is about 100 mg/day, about 125 mg/day, about 150 mg/day, or about 175 mg/day.

### Claim 16 (depends on 4)

The method of claim 4, wherein the amount of the compound is about 200 mg/day, about 225 mg/day, about 250 mg/day, or about 275 mg/day.

### Claim 17 (depends on 4)

The method of claim 4, wherein the amount of the compound is about 300 mg/day, about 325 mg/day, about 350 mg/day, or about 375 mg/day.

### Claim 18 (depends on 4)

The method of claim 4, wherein the amount of the compound is about 400 mg/day, about 425 mg/day, about 450 mg/day, about 475 mg/day, or about 500 mg/day.

### Claim 19 (depends on 5)

The method of claim 5, wherein the amount of the compound is about 500 mg/day, about 525 mg/day, about 550 mg/day, or about 575 mg/day.

### Claim 20 (depends on 5)

The method of claim 5, wherein the amount of the compound is about 600 mg/day, about 625 mg/day, about 650 mg/day, or about 675 mg/day.

### Claim 21 (depends on 5)

The method of claim 5, wherein the amount of the compound is about 700 mg/day, about 725 mg/day, about 750 mg/day, or about 775 mg/day.

### Claim 22 (depends on 5)

The method of claim 5, wherein the amount of the compound is about 800 mg/day, about 825 mg/day, about 850 mg/day, or about 875 mg/day.

### Claim 23 (depends on 5)

The method of claim 5, wherein the amount of the compound is about 900 mg/day, about 925 mg/day, about 950 mg/day, about 975 mg/day, or about 1000 mg/day.

### Claim 24 (depends on 1, 2)

The method of claim 1 or 2, wherein the amount of compound is about 5 mg/day to about 100 mg/day.

### Claim 25 (depends on 1, 2)

The method of any one of claims 1, 2, and 24, wherein the amount of the compound is about 5 mg/day to about 25 mg/day.

### Claim 26 (depends on 1, 2)

The method of any one of claims 1, 2, and 24, wherein the amount of the compound is about 25 mg/day to about 50 mg/day.

### Claim 27 (depends on 1, 2)

The method of any one of claims 1, 2, and 24, wherein the amount of the compound is about 50 mg/day to about 75 mg/day.

### Claim 28 (depends on 1, 2)

The method of any one of claims 1, 2, and 24, wherein the amount of the compound is about 5 mg/day, about 10 mg/day, about 25 mg/day, about 50 mg/day, or about 75 mg/day.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any one of claims 1-28, wherein the % w/w of the compound in the tablet is about 5% to about 30% w/w.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 1-29, wherein the % w/w of the compound in the tablet is about 5% to about 10% w/w.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 1-29, wherein the % w/w of the compound in the tablet is about 20% to about 30% w/w.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 1-31, wherein each component of the tablet is intragranular.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 1-31, wherein at least one component of the tablet, other than the compound, is extragranular.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 1-33, wherein the tablet is a coated tablet.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 1-34, wherein the amount of the compound is administered in one dose per day.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 1-35, wherein the amount of the compound is administered in two equally divided doses per day.

### Claim 37 (depends on 24)

The method of claim 24, wherein 25 mg of the compound is administered twice per day (BID).

### Claim 38 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein 75 mg of the compound is administered twice per day (BID).

### Claim 39 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein 150 mg of the compound is administered once per day (QD).

### Claim 40

A method of treating or preventing a disease or disorder associated with a genetic defect in phenylalanine hydroxylase, comprising orally administering to a patient in need thereof an effective amount of the following compound, or a pharmaceutically acceptable salt thereof:
wherein the compound is formulated as a suspension.

### Claim 41 (depends on 40)

The method of claim 40, wherein the amount of compound is about 5 mg/day to about 1525 mg/day

### Claim 42 (depends on 40, 41)

The method of claim 40 or 41, wherein the amount of compound is about 10 mg/day to about 750 mg/day

### Claim 43 (depends on 40, 41, 42)

The method of any one of claims 40-42, wherein the amount of the compound is about 10 mg/day to about 525 mg/day.

### Claim 44 (depends on 40, 41, 42, 43)

The method of any one of claims 40-43, wherein the amount of the compound is about 25 mg/day to about 100 mg/day.

### Claim 45 (depends on 40, 41, 42, 43)

The method of any one of claims 40-43, wherein the amount of the compound is about 150 mg/day to about 250 mg/day.

### Claim 46 (depends on 40, 41, 42, 43)

The method of any one of claims 40-43, wherein the amount of the compound is about 300 mg/day to about 500 mg/day.

### Claim 47 (depends on 40, 41, 42, 43, 44)

The method of any one of claims 40-44, wherein the amount of the compound is about 25 mg/day.

### Claim 48 (depends on 40, 41, 42, 43, 44)

The method of any one of claims 40-44, wherein the amount of the compound is about 75 mg/day.

### Claim 49 (depends on 40, 41, 42, 43, 45)

The method of any one of claims 40-43 and 45, wherein the amount of the compound is about 150 mg/day.

### Claim 50 (depends on 40, 41, 42, 43, 45)

The method of any one of claims 40-43 and 45, wherein the amount of the compound is about 250 mg/day.

### Claim 51 (depends on 40, 41, 42, 43, 46)

The method of any one of claims 40-43 and 46, wherein the amount of the compound is about 300 mg/day.

### Claim 52 (depends on 40, 41, 42, 43, 46)

The method of any one of claims 40-43 and 46, wherein the amount of the compound is about 500 mg/day.

### Claim 53 (depends on 40, 41)

The method of claim 40 or 41, wherein the amount of compound is about 750 mg/day to about 1000 mg/day

### Claim 54 (depends on 40, 41, 42, 43)

The method of any one of claims 40-43, wherein the amount of the compound is about 1000 mg/day to about 1500 mg/day.

### Claim 55 (depends on 53, 54)

The method of any one of claims 53-54, wherein the amount of the compound is about 1000 mg/day.

### Claim 56 (depends on 53, 54)

The method of any one of claims 53-54, wherein the amount of the compound is about 1500 mg/day.

### Claim 57 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The method of any one of claims 40-56, wherein the % w/w of the compound in the suspension is about 25% to about 95% w/w.

### Claim 58 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The method of any one of claims 40-57, wherein the % w/w of the compound in the t suspension is about 33% to about 60% w/w.

### Claim 59 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The method of any one of claims 40-57, wherein the % w/w of the compound in the suspension is about 75% to about 90% w/w.

### Claim 60 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The method of any one of claims 40-57, wherein the % w/w of the compound in the suspension is about 90% to about 95% w/w.

### Claim 61 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The method of any one of claims 40-60, wherein the suspension consists of the compound, a wetting agent, and a vehicle.

### Claim 62 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)

The method of any one of claims 40-61 wherein the amount of the compound is administered in one dose per day.

### Claim 63 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)

The method of any one of claims 40-61, wherein the amount of the compound is administered in two equally divided doses per day.

### Claim 64 (depends on 40, 41, 42, 43, 44)

The method of any one of claims 40-44, wherein 25 mg of the compound is administered twice per day (BID).

### Claim 65 (depends on 40, 41, 42, 43)

The method of any one of claims 40-43, wherein 75 mg of the compound is administered twice per day (BID).

### Claim 66 (depends on 40, 41, 42, 43)

The method of any one of claims 40-43, wherein 150 mg of the compound is administered once per day (QD).

### Claim 67 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The method of any one of claims 1-66, wherein the treatment continues indefinitely.

### Claim 68 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67)

The method of any one of claims 1-67, wherein the patient is a human.

### Claim 69 (depends on 68)

The method of claim 68, wherein the patient is an adult.

### Claim 70 (depends on 62)

The method of claim 62, wherein the patient is an elderly adult.

### Claim 71 (depends on 68)

The method of claim 68, wherein the patient is a child.

### Claim 72 (depends on 68)

The method of claim 68, wherein the patient is an infant or a toddler.

### Claim 73 (depends on 68, 69, 70, 71, 72)

The method of any one of claims 68-72, wherein the patient is a male.

### Claim 74 (depends on 68, 69, 70, 71, 72)

The method of any one of claims 68-72, wherein the patient is a female.

### Claim 75 (depends on 68, 69, 70, 71, 72, 73, 74)

The method of any one of claims 68-74, wherein the human is of African ancestry, Asian ancestry, Caucasian ancestry, American Indian ancestry, Hispanic/Latino ancestry, or Pacific Islander ancestry.

### Claim 76 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75)

The method of any one of claims 1-75, wherein the concentration of phenylalanine in the blood of the patient is reduced relative to pretreatment baseline.

### Claim 77 (depends on 76)

The method of claim 76, wherein the concentration of phenylalanine is reduced by at least 1%, at least 2%, at least 3%, at least 4%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 11%, at least 12%, at least 13%, at least 14%, at least 15%, at least 16%, at least 17%, at least 18%, at least 19%, at least 20%, at least 21%, at least 22%, at least 23%, at least 24%, at least 25%, at least 26%, at least 27%, at least 28%, at least 29%, at least 30%, at least 31%, at least 32%, at least 33%, at least 34%, at least 35%, at least 36%, at least 37%, at least 38%, at least 39%, at least 40%, at least 41%, at least 42%, at least 43%, at least 44%, at least 45%, at least 46%, at least 47%, at least 48%, at least 49%, at least 50%, at least 51%, at least 52%, at least 53%, at least 54%, at least 55%, at least 56%, at least 57%, at least 58%, at least 59%, at least 60%, at least 61%, at least 62%, at least 63%, at least 64%, at least 65%, at least 66%, at least 67%, at least 68%, at least 69%, at least 70%, at least 71%, at least 72%, at least 73%, at least 74%, at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%.

### Claim 78 (depends on 76)

The method of claim 76, wherein the concentration of phenylalanine is reduced by at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90%.

### Claim 79 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78)

The method of any one of claims 1-78, wherein the disease or disorder associated with a genetic defect in phenylalanine hydroxylase is phenylketonuria.

### Claim 80 (depends on 79)

The method of claim 79, wherein the phenylketonuria is classical phenylketonuria.

### Claim 81 (depends on 79)

The method of claim 79, wherein the phenylketonuria is mild phenylketonuria.

### Claim 82 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78)

The method of any one of claims 1-78, wherein the disease or disorder associated with a genetic defect in phenylalanine hydroxylase is hyperphenylalaninemia.

### Claim 83 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82)

The method of any one of claims 1-82, wherein the compound inhibits SLC6A19 in the patient.
